Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The ATLAST Long-Term Study. A Multicenter, Prospective, Long-Term Study of the Attune Sleep Apnea System for the Treatment of Obstructive Sleep Apnea (OSA)

NCT01476917 is registered in ClinicalTrials.gov with ApniCure, Inc. as lead sponsor.

NCT NCT01476917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01476917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The ATLAST Long-Term Study. A Multicenter, Prospective, Long-Term Study of the Attune Sleep Apnea System for the Treatment of Obstructive Sleep Apnea (OSA)
Lead sponsor
ApniCure, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2011
Completion date
October 31, 2012
Enrollment
39 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea (osa)